PROCEPT BioRobotics Corporation Common Stock
PRCT Real Time Price USDRecent trades of PRCT by members of U.S. Congress
|
Name
|
Type
|
Shares
|
Price
|
Shares Held
|
Date
|
Reported
|
|---|
|
Investor
|
Shares
|
Change in Shares
|
Market Value
|
Date
|
Reported
|
|---|
|
Investor
|
Type
|
Shares
|
Change in Shares
|
Market Value
|
Date
|
Reported
|
|---|
Recently reported changes by institutional investors
Quarterly net insider trading by PRCT's directors and management
* Insider trading data parsed from SEC Form 4 filings by Quiver Quantitative. Sign up for the Quiver API for real-time access.
- 1M
- 3M
- 6M
- YTD
- 1Y
- 2Y
- 5Y
- MAX
About
Key Metrics
Return (1d)
Return (30d)
Return (1Y)
CAGR (Total)
Max Drawdown
Beta
Alpha
Sharpe Ratio
Win Rate
Average Win
Average Loss
Annual Volatility
Annual Std Dev
Information Ratio
Treynor Ratio
Total Trades
Metrics Definitions
-
Alpha
Measures a portfolio's risk-adjusted performance against that of its benchmark
Learn More -
Annual Standard Deviation
Measures how much the portfolio's total return varies from its mean or average.
Learn More -
Annual Volatility
A statistical measure of the dispersion of returns for the portfolio.
Learn More -
Average Win
The average return (%) for trades that resulted in a positive return.
-
Average Loss
The average return (%) for trades that resulted in a negative return.
-
Beta
A measure of the volatility of the portfolio compared to the market as a whole.
Learn More -
CAGR
CAGR (Compounded Annual Growth Rate), is the historical annualized rate of return for an investment strategy, throughout the backtest period.
Learn More -
Information Ratio
A measurement of portfolio returns beyond the returns of its benchmark compared to the volatility of those returns.
Learn More -
Max Drawdown
the maximum observed loss from a peak to a trough of a portfolio, before a new peak is attained.
Learn More -
Sharpe Ratio
The Sharpe Ratio is a measure of historical risk-adjusted return, which quantifies the amount of return that an investor received per unit of risk.
Learn More -
Total Trades
The total number of trades made by this strategy.
-
Treynor Ratio
Attempts to measure how successful an investment is in providing compensation to investors for taking on investment risk.
Learn More -
Win Rate
The percentage of total trades that resulted in a positive return.
Be the first to see our newest insights and key updates across all datasets.
Government lobbying spending instances
Estimated quarterly lobbying spending
PRCT Revenue by Segment or Geography
New patents grants
-
Patent Title: Method for removing intact cells from a surgical site Jan. 28, 2025
-
Patent Title: Systems for defining and modifying range of motion of probe used in patient treatment Dec. 31, 2024
-
Patent Title: Surgical probe with independent energy sources Dec. 31, 2024
-
Patent Title: Pump cartridge and console Nov. 19, 2024
-
Patent Title: Robotic arms and methods for tissue resection and imaging Sep. 17, 2024
-
Patent Title: Stiff sheath for imaging probe Sep. 10, 2024
-
Patent Title: Tissue treatment with pulsatile shear waves Aug. 06, 2024
-
Patent Title: Water enucleation of the prostate Aug. 06, 2024
-
Patent Title: Artificial intelligence for robotic surgery Apr. 23, 2024
-
Patent Title: Tissue treatment with pulsatile shear waves Feb. 20, 2024
-
Patent Title: Integration of robotic arms with surgical probes Jan. 23, 2024
-
Patent Title: Tensioning apparatus for hemostasis and maintaining catheter placement Jan. 16, 2024
-
Patent Title: Surgical drape with container Jan. 02, 2024
-
Patent Title: Systems and methods for defining and modifying range of motion of probe used in patient treatment Oct. 03, 2023
-
Patent Title: Stiff sheath for imaging probe Sep. 12, 2023
-
Patent Title: Automated image-guided tissue resection and treatment Aug. 29, 2023
-
Patent Title: Minimally invasive systems with expandable supports for hemostasis in a bleeding closed tissue volume Jan. 17, 2023
-
Patent Title: Automated image-guided tissue resection and treatment Oct. 11, 2022
-
Patent Title: Physician controlled tissue resection integrated with treatment mapping of target organ images Aug. 09, 2022
-
Patent Title: Fluid jet tissue ablation apparatus Jun. 07, 2022
-
Patent Title: Water enucleation of the prostate May. 24, 2022
-
Patent Title: Method of using surgical drape Apr. 19, 2022
-
Patent Title: Minimally invasive methods for hemostasis in a bleeding closed tissue volume without occlusion Mar. 22, 2022
-
Patent Title: Surgical drape with sterile barrier Mar. 01, 2022
-
Patent Title: Tissue resection and treatment with shedding pulses Jan. 04, 2022
-
Patent Title: Apparatus for removing intact cells from a surgical site Dec. 28, 2021
-
Patent Title: Systems and methods for defining and modifying range of motion of probe used in patient treatment Aug. 24, 2021
-
Patent Title: Surgical drape with canopy Aug. 03, 2021
-
Patent Title: Surgical probes for tissue resection with robotic arms Jul. 27, 2021
-
Patent Title: Tissue sampling and catheter selection cancer treatment methods Jul. 20, 2021
-
Patent Title: Automated image-guided tissue resection and treatment May. 19, 2020
-
Patent Title: Gene analysis and generation of stem cell methods and apparatus Mar. 17, 2020
-
Patent Title: Image-guided eye surgery apparatus Jan. 07, 2020
-
Patent Title: Fluid jet tissue resection and cold coagulation methods Oct. 22, 2019
-
Patent Title: Tissue sampling, cancer detection and treatment methods Aug. 06, 2019
-
Patent Title: Cancer treatment apparatus Jul. 09, 2019
-
Patent Title: Minimally invasive methods for hemostasis in a bleeding closed tissue volume Jun. 11, 2019
-
Patent Title: Cancer detection and treatment apparatus Jan. 22, 2019
-
Patent Title: Water enucleation of the prostate Oct. 16, 2018
-
Patent Title: Prostate treatment apparatus Jul. 10, 2018
-
Patent Title: Tissue resection and treatment with shedding pulses Dec. 26, 2017
-
Patent Title: Automated image-guided tissue resection and treatment Jun. 06, 2017
-
Patent Title: Tissue resection and treatment with shedding pulses Dec. 06, 2016
-
Patent Title: Automated image-guided tissue resection and treatment Dec. 06, 2016
-
Patent Title: Automated image-guided tissue resection and treatment Jun. 14, 2016
Federal grants, loans, and purchases
Estimated quarterly amount awarded from public contracts
Recent insights relating to PRCT
Recent picks made for PRCT stock on CNBC
ETFs with the largest estimated holdings in PRCT
- ... Highest Price Target
- ... Median Price Target
- ... Lowest Price Target
|
Analyst
|
Firm
|
Current
|
Previous
|
Date
|
|---|
- Is $PRCT stock a Buy, Sell, or Hold?
- What is the price target for $PRCT stock?
* Analyst consensus is not financial advice. Please see our data disclaimers .
|
Shareholder
|
Shares Held
|
|---|
- Who owns $PRCT stock?
- Who owns the most shares of $PRCT stock?
- What funds own $PRCT stock?
* These are estimates based on data taken from SEC filings. There may be inaccuracies due to parsing errors, accidental double-counting, incorrect classification of indirectly owned shares, or any other number of issues.
The Quiver Smart Score combines our data on Congress Trading, Lobbying, Insider Trading, CNBC Mentions and more to provide a comprehensive view of the strength of a stock's underlying data.
The Smart Score grades stocks on a scale of 1 (weakest) to 10 (strongest) based on the strength of the underlying data.Sign Up to view PRCT Smart Score
See concise summaries of analyst reports, presenting both bullish and bearish arguments for a stock.
Example:
The Bulls Say summary highlights positive aspects of the stock.
The Bears Say summary points out potential risks and negative aspects of the stock.